From: Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study
Antibiotics | Resistant rate (%) |
---|---|
Piperacillin | 45.0% |
Ciprofloxacin | 30.0% |
Levofloxacin | 27.5% |
Moxifloxacin | 30.0% |
Tobramycin | 27.5% |
Gentamicin | 36.8% |
Cefotaxime | 83.9% |
Ceftazidime | 52.5% |
Ceftriaxone | 97.4% |
Cefepime | 37.5% |
Trimethoprim-sulfamethoxazole | 17.5% |
Ampicillin-sulbactam | 34.2% |
Piperacillin-tazobactam | 40.0% |
Cefoperazone-sulbactam | 50.0% |
Meropenem | 46.2% |
Imipenem | 40.0% |
Doripenem | 48.4% |
Tetracycline | 19.4% |
Minocycline | 7.7% |
Doxycycline | 10.0% |
Tigecycline | 19.4% |
Colistin | 0.0% |